Hypothyroidism: Pathology review

Last updated: January 21, 2026

Hypothyroidism: Pathology review

Watch later

Watch later

Nernst equation
Cytoskeleton and intracellular motility
Cell signaling pathways
Resting membrane potential
Gene regulation
Epigenetics
Nuclear structure
DNA structure
Transcription of DNA
Amino acids and protein folding
Necrosis and apoptosis
Endometrial hyperplasia and cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Lung cancer
Asthma
Atrial septal defect
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Angina pectoris
Aortic valve disease
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Coarctation of the aorta
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Heart failure
Mitral valve disease
Cor pulmonale
Heart failure: Pathology review
Myocarditis
Diabetes mellitus: Pathology review
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Abnormal uterine bleeding: Clinical
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Neisseria gonorrhoeae
Pelvic inflammatory disease
Polycystic ovary syndrome
Benign prostatic hyperplasia
Thyroid hormones
Testosterone
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Primary adrenal insufficiency
Hyperthyroidism: Pathology review
Chronic leukemia
Anemia of chronic disease
Hemophilia
Heparin-induced thrombocytopenia
Hypocalcemia
Hypermagnesemia
Hypokalemia
Hypomagnesemia
Inflammation
Innate immune system
Complement system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Vaccinations
Acute pyelonephritis
Celiac disease
Cirrhosis
Congenital disorders: Clinical
Appendicitis
Autoimmune hepatitis
Bowel obstruction
Chronic cholecystitis
Chronic pyelonephritis
Crohn disease
Gastroesophageal reflux disease (GERD)
Nephrotic syndromes: Pathology review
Irritable bowel syndrome
Lower urinary tract infection
Biliary colic
Peptic ulcer
Renal failure: Pathology review
Urinary tract infections: Pathology review
Viral hepatitis
Pancreatitis: Pathology review
Alcohol-associated liver disease
Ulcerative colitis
Medullary cystic kidney disease
Small bowel ischemia and infarction
Chronic kidney disease
Acute cholecystitis
Skin cancer
Autosomal trisomies: Pathology review
Selective permeability of the cell membrane
Free radicals and cellular injury
Pericarditis and pericardial effusion
Peripheral artery disease
Cauda equina syndrome
Cranial nerves
Dementia: Pathology review
Arteriovenous malformation
Bipolar and related disorders
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Myasthenia gravis
Panic disorder
Parkinson disease
Alzheimer disease
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Coagulation disorders: Pathology review
Factor V Leiden
Hodgkin lymphoma
Disseminated intravascular coagulation
Non-Hodgkin lymphoma
Introduction to the immune system
Acute pancreatitis
Approach to congenital heart diseases (acyanotic): Clinical sciences
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Varicella zoster virus
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Role of Vitamin K in coagulation
Loop diuretics
Miscellaneous lipid-lowering medications
Potassium sparing diuretics
Adrenergic antagonists: Alpha blockers
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class I antiarrhythmics: Sodium channel blockers
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Anti-mite and louse medications
Antimalarials
Hepatitis medications
Anthelmintic medications
Integrase and entry inhibitors
Antimetabolites: Sulfonamides and trimethoprim
Azoles
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Echinocandins
Herpesvirus medications
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Neuraminidase inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Antihistamines for allergies
Miscellaneous antifungal medications
Antituberculosis medications
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
PDE5 inhibitors
Progestins and antiprogestins
Uterine stimulants and relaxants
Acid reducing medications
Antidiarrheals
Laxatives and cathartics
Non-corticosteroid immunosuppressants and immunotherapies
Hyperthyroidism medications
Hypoglycemics: Insulin secretagogues
Hypothyroidism medications
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Sympatholytics: Alpha-2 agonists
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Atypical antipsychotics
Atypical antidepressants
Typical antipsychotics
Lithium
Monoamine oxidase inhibitors
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Anti-parkinson medications
Tricyclic antidepressants
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Migraine medications
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Antigout medications
Folate (Vitamin B9) deficiency
Vitamin D
Fat-soluble vitamin deficiency and toxicity: Pathology review
Approach to viral exanthems (pediatrics): Clinical sciences
Mumps virus
Measles virus
Rubella virus
Bordetella pertussis (Whooping cough)
Poliovirus

Transcript

Watch video only

In this scenario, there are two individuals at the emergency department. The first one is 23-year-old Hannah who reports lethargy, fatigue, reduced appetite, muscle weakness and constipation. She also says that lately she gained a bit of weight and has a low libido. On clinical examination, she has periorbital edema, dry, cool skin, her nails are brittle, and her reflexes are slow. She also has a moderately enlarged, painless goiter.

The other one is 33-year-old Quentin, who also presents with lethargy, fatigue, reduced appetite, muscle weakness, constipation and he’s also complaining about feeling cold all the time. He said that he recently had the flu, but no other illnesses. On clinical examination, there’s periorbital edema, dry, cool skin, brittle nails and hair, and a very painful goiter.

TSH, free T3, and free T4 are taken, along with antithyroid-peroxidase and antithyroglobulin antibodies. Both Hannah and Quentin have high levels of TSH and low T3 and T4 levels, but Hannah has positive antithyroid-peroxidase and antithyroglobulin antibodies. Both individuals seem to have hypothyroidism.

First, a bit of physiology. Normally, the hypothalamus detects low serum levels of thyroid hormones and releases thyrotropin-releasing hormone or TRH into the hypophyseal portal system. The anterior pituitary then releases thyroid-stimulating hormone, also called thyrotropin or simply TSH. TSH stimulates the thyroid gland.

The thyroid gland is made up of thousands of follicles, which are small spheres lined with follicular cells. Follicular cells convert thyroglobulin, a protein found in follicles, into two iodine-containing hormones, triiodothyronine or T3, and thyroxine or T4. Once released from the thyroid gland, these hormones enter the blood and bind to circulating plasma proteins. Only a small amount of T3 and T4 will travel unbound, or free, in the blood, and this is the form that acts upon nearly every type of cell in the body.

Once inside the cell T­4 is usually converted into T3, and it can exert its effect. T3 speeds up the cell’s basal metabolic rate. It increases cardiac output, stimulates bone resorption, basically thinning out the bones, and activates the sympathetic nervous system. Thyroid hormones are also involved in a number of other things, like controlling sebaceous and sweat gland secretion, hair follicle growth, and regulating proteins and mucopolysaccharide synthesis by skin fibroblasts.

Now, hypothyroidism can happen a few different ways, and all of them result in a decrease in thyroid hormones and a decreased basal metabolic rate, where cellular reactions are happening slower than normal. There are three types of hypothyroidism. In primary hypothyroidism, the thyroid gland is the problem, because it isn’t making enough thyroid hormones. Not only is there a lack of T3 and T4 which causes a slowing down of metabolic processes, but there are increased levels of TSH from the pituitary to try to stimulate the gland. A secondary effect of the high levels of TSH is that it stimulates fibroblasts in the skin and soft tissues. The stimulated fibroblasts start depositing glycosaminoglycans in the interstitium.

Secondary hypothyroidism is caused by damage to the pituitary and tertiary hypothyroidism is caused by damage to the hypothalamus. These are sometimes called central hypothyroidism. A high yield fact for your exam is that they can lead to a decrease in TSH release, which decreases the activity of the thyroid.

Regardless of the cause, symptoms of hypothyroidism are the same and in order to remember them better, keep in mind that hypothyroidism slows down almost everything. They can take years to manifest and affect multiple systems. Metabolic findings include modest weight gain, and cold intolerance due to the low basal metabolic rate. Skin and hair findings include cool skin due to vasoconstriction, dry skin due to reduced secretion of the sweat glands and sebaceous glands. The hair is coarse and brittle and there can be diffuse alopecia, and the nails are also brittle.

Hypothyroidism leads to an increase in glycosaminoglycans in the interstitium, which can elevate the osmotic pressure, leading to water retention and eventually non-pitting edema. As a result, the individual has a puffy appearance, called myxedema. Ocular findings include periorbital edema.

Gastrointestinal findings include constipation due to low GI motility and there’s also reduced appetite. Musculoskeletal findings include hypothyroid myopathy which presents with muscle weakness, especially proximal weakness, Sometimes, there can also be muscle damage and in this case, CK levels are increased.

It’s not exactly understood why this happens, but it’s known that thyroid hormones have a great influence on cell metabolism, and this includes muscle cell metabolism. Sometimes, carpal tunnel syndrome can appear, and it’s thought that this happens due to the accumulation of glycosaminoglycans. There can also be myoedema which is a bump caused by local muscle contraction when triggered by light percussion with an object. The prolonged muscle contraction is a result of the alterations in muscle fibers caused by hypothyroidism.

Reproductive findings can include menorrhagia and oligomenorrhea in those with a uterus, as well as, low libido and even infertility in people of any sex. These changes can occur due to deficient LH secretion. Neuropsychiatric findings include hypoactivity, lethargy, fatigue, weakness, depressed mood and slower reflexes. Finally, cardiovascular findings include bradycardia and dyspnea.

Diagnosing hypothyroidism is done by measuring blood levels of TSH, free T4, and sometimes free T3. In all cases, thyroid hormones will be low, but TSH levels vary. If it’s due to a primary cause, TSH will be high, and if it’s due to a central cause, TSH will either be low or normal. There can also be hypercholesterolemia, due to low LDL receptor expression.

Okay, let’s now start talking about causes of hypothyroidism, starting with causes of primary hypothyroidism. First, there’s chronic autoimmune, or Hashimoto thyroiditis, which is the most common cause of primary hypothyroidism in countries that fortify foods with iodine. This is an autoimmune disorder where T cells and autoantibodies like anti-thyroid peroxidase and thyroglobulin antibodies infiltrate the thyroid - remember these antibodies because this is very high yield!

Now, there are several types of genes involved in the regulation of the immune response, including the human leukocyte antigen, or HLA, system and the cytotoxic T lymphocyte-associated antigen, or CTLA, system.

Interestingly, individuals with Hashimoto thyroiditis often have specific immune-regulatory genes in common with each other. In addition, individuals with another autoimmune disorder are more likely to develop Hashimoto thyroiditis.

Damage to some parts of the thyroid, and the subsequent increase in TSH, leads to thyroid hypertrophy and hyperplasia. In other words, the thyroid responds to autoimmune damage by increasing the size and number of healthy follicular cells, both of which cause the thyroid to enlarge. Unfortunately, this compensation is short-lived, and eventually the autoantibodies cause so much follicular cell damage that they destroy thyroid function altogether. In the beginning, as the follicles rupture, they release a pretty high amount of thyroid hormone, resulting in an initial phase of hyperthyroidism.

On histology, with Hashimoto thyroiditis, there can be Hürthle cells, which are also called oncocytes. These cells arise from the follicular epithelium, have an eosinophilic cytoplasm, and a vesicular nucleus with a large nucleolus.

There can also be lymphoid aggregates with germinal centers. On clinical examination, there can be a goiter, which is an enlarged thyroid gland, that doesn’t cause pain. In individuals with Hashimoto thyroiditis, there’s a higher risk for developing lymphoma.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Riedel's Thyroiditis: A Clinical Review" The Journal of Clinical Endocrinology & Metabolism (2011)
  4. "The History and Future of Treatment of Hypothyroidism" Annals of Internal Medicine (2016)
  5. "Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges" The Journal of Clinical Endocrinology & Metabolism (2012)
  6. "Hypothyroidism" Aust Fam Physician (2014)
  7. "Approach to the Patient with Postpartum Thyroiditis" The Journal of Clinical Endocrinology & Metabolism (2012)